Multiple Sclerosis Medication Injections

    Basic Details
    Date Posted
    Wednesday, January 8, 2014
    Status
    Complete
    Medical Product
    injection glatiramer acetate
    injection interferon beta-1A
    injection interferon beta-1A
    injection interferon beta-1B
    injection mitoxantrone HCL
    injection natalizumab
    Description

    Summary table assessment of the use of eleven multiple sclerosis procedure codes: Injection Glatiramer Acetate 20 MG (HCPCS code J1595), Injection Interferon Beta-1A 33 MCG (HCPCS code J1825), Injection Interferon Beta-1A 30 MCG (HCPCS code J1826),  Injection Interferon Beta-1B 0.25 MG (HCPCS code J1830),  Injection Natalizumab 1 MG (HCPCS code J2323),  Injection Mitoxantrone HCL Per 5 MG (HCPCS code J9293),   Injection Glatiramer Acetate Per Dose (HCPCS code Q2010),  Injection Interferon Beta-1A 11 MCG Intramuscular Use (HCPCS code Q3025),  Injection Interferon Beta-1A 11 MCG Subcutaneous Use (HCPCS code Q3026),  Injection Natalizumab Per 1 MG (HCPCS code Q4079),  and Injection Natalizumab Per 5 MG (HCPCS code C9126). Results were generated using the Mini-Sentinel Distributed Query Tool and the HCPCS Summary Table. Summary tables are precompiled stratified counts. Queries were executed in February 2013. This report includes data from 17 Data Partners.


    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2000 - 2012
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)